AI Article Synopsis

  • Egyptian rousette bats (ERBs) are linked to several bunyaviruses, particularly Kasokero virus (KASV), which was first recognized in Uganda in 1977.
  • In a study, researchers examined tissue samples from KASV-infected ERBs to analyze liver damage, immune responses, and virus clearance, finding significant liver lesions but no clinical disease.
  • KASV primarily replicated in the liver and was mostly cleared from both the liver and spleen by 6 days post-infection, indicating that ERBs can effectively manage KASV without severe health consequences.

Article Abstract

Egyptian rousette bats (ERBs; ; family ) are associated with a growing number of bunyaviruses of public health importance, including Kasokero virus (KASV), which was first identified as a zoonosis in Uganda in 1977. In this study, formalin-fixed paraffin-embedded tissues from a previous experiment in which KASV infection was confirmed in 18 experimentally infected ERBs were used for an in-depth analysis using histopathology, in situ hybridization (ISH) for detection of viral RNA, immunohistochemistry (IHC) to assess the mononuclear phagocyte system response, and quantitative digital image analysis to investigate virus clearance from the liver and spleen within a spatial context. Significant gross and histological lesions were limited to the liver, where KASV-infected bats developed mild to moderate, acute viral hepatitis, which was first observed at 3 days postinfection (DPI), peaked at 6 DPI, and was resolved by 20 DPI. A subset of bats had glycogen depletion ( = 10) and hepatic necrosis ( = 3), rarely with intralesional bacteria ( = 1). Virus replication was confirmed by ISH in the liver, spleen, lymph nodes, and tongue. In the liver, KASV replicated in the cytoplasm of hepatocytes, to a lesser extent in mononuclear phagocytes, and rarely in presumptive endothelial cells. Most KASV RNA, as detected by ISH, was cleared from the spleen and liver by 6 DPI. It is concluded that ERBs have effective mechanisms to respond to this virus, clearing it without evidence of clinical disease.

Download full-text PDF

Source
http://dx.doi.org/10.1177/03009858231158076DOI Listing

Publication Analysis

Top Keywords

kasokero virus
8
experimentally infected
8
egyptian rousette
8
rousette bats
8
liver spleen
8
virus
5
liver
5
pathogenesis kasokero
4
virus experimentally
4
infected egyptian
4

Similar Publications

Tick salivary gland components dampen Kasokero virus infection and shedding in its vertebrate reservoir, the Egyptian rousette bat (Rousettus aegyptiacus).

Parasit Vectors

July 2023

Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.

Background: The human-pathogenic Kasokero virus (KASV) circulates in an enzootic transmission cycle between Egyptian rousette bats (ERBs; Rousettus aegyptiacus) and their argasid tick ectoparasites, Ornithodoros (Reticulinasus) faini. Although tick salivary gland components have been shown to potentiate virus infection in vertebrate non-reservoirs (i.e.

View Article and Find Full Text PDF
Article Synopsis
  • Egyptian rousette bats (ERBs) are linked to several bunyaviruses, particularly Kasokero virus (KASV), which was first recognized in Uganda in 1977.
  • In a study, researchers examined tissue samples from KASV-infected ERBs to analyze liver damage, immune responses, and virus clearance, finding significant liver lesions but no clinical disease.
  • KASV primarily replicated in the liver and was mostly cleared from both the liver and spleen by 6 days post-infection, indicating that ERBs can effectively manage KASV without severe health consequences.
View Article and Find Full Text PDF
Article Synopsis
  • The Kasokero virus (KASV) has been isolated from Egyptian rousette bats and ticks, indicating a possible cycle of transmission between these species.
  • A study inoculated these bats to evaluate their potential as reservoirs for KASV, showing high virus replication without apparent illness.
  • Results suggest ERBs are competent reservoirs for KASV and may transmit the virus to other bats and potentially humans through contact with their excretions.
View Article and Find Full Text PDF
Article Synopsis
  • The Kasokero virus (KASV) was first discovered in 1977 in bats in Uganda and is linked to both mild and severe illnesses in humans.
  • Despite being part of a group of viruses usually transmitted by ticks or vertebrates, a tick vector for KASV was not identified until recent studies.
  • Testing 786 tick pools from bat habitats revealed KASV RNA in several pools, suggesting KASV is spread between O. (R.) faini ticks and R. aegyptiacus bats, with potential risks for human transmission.
View Article and Find Full Text PDF

A number of arboviruses have previously been isolated from naturally-infected East African bats, however the role of bats in arbovirus maintenance is poorly understood. The aim of this study was to investigate the exposure history of Ugandan bats to a panel of arboviruses. Insectivorous and fruit bats were captured from multiple locations throughout Uganda during 2009 and 2011-2013.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!